Down We Go?
Yesterday, we discussed how the market had shown relative strength recently and asked the question whether the bullish sentiment would last. While it’s hard to know precisely when a bottom will take place, we highlighted the danger of trying to pick the low point because inevitably at some stage betting on the bottom will lead to a losing trade where lower lows follow. » Read more about: Down We Go? »
Read More
Is It Smart To Buy Stocks Now?
A bear market happens when prices drop by at least 20%, creating a chance to buy shares at discounted prices. It’s the classic “buy low and sell high” approach to making money from the stock market. But some stocks are broken. Share prices of high flying companies that subsequently got crushed 80-90% may never recover to former highs.
» Read more about: Is It Smart To Buy Stocks Now? »
Read More
2 Stocks This Billionaire Is Buying Hand Over Fist
Warren Buffet isn’t the only one purchasing millions of dollars’ worth of shares. Another billionaire who has recently caught the attention of investors is Ken Griffin, an American hedge fund manager, entrepreneur, and investor. Since 2022 began, Griffin has heavily invested in two stocks that he’s buying hand over fist.
Should these stocks be on your shortlist of investment candidates?
» Read more about: 2 Stocks This Billionaire Is Buying Hand Over Fist »
Read More
Survive The Bear Market With 11 Top Dividend Stocks
A bear market demands that investors travel down the risk curve from higher risk, high growth stocks towards value-based dividend stocks. Investing in top dividend stocks creates several potential benefits that can help you weather a bear market, including:
Reinvesting Dividends Grows Your Stock Ownership
When a company pays out dividends,
» Read more about: Survive The Bear Market With 11 Top Dividend Stocks »
Read More
Is This Little-Known Health Innovation The Next Big Thing?
It’s hard to find the next big thing but Exact Sciences might be as close as any company is to it via its liquid biopsies, a transformative approach to diagnosing and monitoring various diseases by detecting signs of cancer, genetic anomalies, or other conditions in blood or other bodily fluids.
This technology has been particularly promising for cancer,
» Read more about: Is This Little-Known Health Innovation The Next Big Thing? »
Read MoreThe Burst
Market Commentary: 3 Cathie Wood’s Stocks Are Soaring Again
It’s been a while but eventually the wheel has come full circle for Cathie Wood, it seems. From the dizzying heights of 2021 to the crushing lows of 2022, Wood and her ARK Invest fund have enjoyed the highest highs and suffered the lowest lows.
Over the past couple of weeks, sentiment has swung back in her favor and some of her stocks have been on an absolute tear,
» Read more about: Market Commentary: 3 Cathie Wood’s Stocks Are Soaring Again »
Read MoreThe Spotlight
Top 3 Healthcare Stocks In Cathie Wood’s Flagship ETF
To say the least, this year hasn’t been kind to Cathie Wood’s “disruptive innovation” investment strategy and her ARK funds. Unfortunately for investors of ARKK, the ETF has been a massive letdown this year, sinking nearly 53% thus far — much worse than the S&P 500, which is down almost 18% year to date.
» Read more about: Top 3 Healthcare Stocks In Cathie Wood’s Flagship ETF »
Read MoreThe Daily
Why Tesla, Inc. (TSLA) Is Plunging So Far in 2025?
AI game is changing.
The chip guys, like Nvidia, they had their moment. The first AI wave? They rode it high.
But guess what? That ride’s over. Nvidia’s been flatlining since June 2024.
Remember the internet boom? Everyone thought Cisco and Intel were the kings, right? Wrong.
» Read more about: Why Tesla, Inc. (TSLA) Is Plunging So Far in 2025? »